Psychemedics Corp (PMDI) — SEC Filings
Psychemedics Corp (PMDI) — 20 SEC filings. Latest: 10-K (Mar 24, 2025). Includes 7 8-K, 3 SC 13D/A, 3 SC 13G/A.
View Psychemedics Corp on SEC EDGAR
Overview
Psychemedics Corp (PMDI) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 10-K filed on Mar 24, 2025: Psychemedics Corp. filed its 10-K for the fiscal year ending December 31, 2024, on March 24, 2025. The filing details the company's financial performance and operations. Key financial activities include various financing arrangements, such as a line of credit with Banc of America Leasing and Capital
Sentiment Summary
Across 20 filings, the sentiment breakdown is: 1 bearish, 18 neutral, 1 mixed. The dominant filing sentiment for Psychemedics Corp is neutral.
Filing Type Overview
Psychemedics Corp (PMDI) has filed 2 10-K, 3 SC 13D/A, 7 8-K, 3 SC 13G/A, 2 DEFA14A, 2 10-Q, 1 DEF 14A with the SEC between Jan 2024 to Mar 2025.
Filings by Year
Recent SEC Filings (20)
Risk Profile
Risk Assessment: Of PMDI's 17 recent filings, 1 were flagged as high-risk, 6 as medium-risk, and 10 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.
Key Executives
- Peter H. Kamin
- David E. Danovitch, Esq.
- Enma Sagastume V
Industry Context
Psychemedics Corp operates in the medical laboratories industry, providing diagnostic testing services.
Top Tags
amendment (4) · financials (3) · sec-filing (3) · corporate-governance (3) · proxy-statement (3) · 10-K (2) · ownership-change (2) · 10-Q (2) · financing (1) · 13D-A (1)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| Fiscal Year End | 2024-12-31 | Reporting period for the 10-K |
| Filing Date | 2025-03-24 | Date the 10-K was submitted to the SEC |
| Filing Amendment | Amendment No. 9 | Indicates this is a significant update to previous filings. |
| Date of Event | December 3, 2024 | The date triggering the requirement for this amended filing. |
| SEC File Number | 001-13738 | Identifies the company's filing history with the SEC. |
| I.R.S. Employer Identification No. | 58-1701987 | Company's tax identification number. |
| Sales Revenue Net | N/A | Specific dollar amounts for sales revenue are not provided in this snippet, but the filing indicates data for CustomerOne and CustomerTwo for periods ending 2023-09-30 and 2024-09-30. |
| Accounts Receivable | N/A | Specific dollar amounts for accounts receivable are not provided in this snippet, but the filing indicates data for CustomerOne and CustomerTwo for periods ending 2023-09-30 and 2024-09-30. |
| Annual Meeting Year | 2024 | The filing pertains to the 2024 Annual Meeting of Stockholders. |
| Period End Date | 2024-03-31 | Conformed period of report |
| Central Index Key | 0000806517 | Filer's Central Index Key |
| SIC Code | 8071 | Standard Industrial Classification |
| Standard Industrial Classification | 8071 | SERVICES-MEDICAL LABORATORIES |
| Business Street Address | 125 Nagog Park | STREET 1 |
| Business City | Acton | CITY |
Forward-Looking Statements
- {"claim":"Renaissance Technologies will continue to adjust its stake in Psychemedics Corporation.","entity":"Renaissance Technologies LLC","targetDate":"Next 12 months","confidence":"medium"}
Related Companies
Frequently Asked Questions
What are the latest SEC filings for Psychemedics Corp (PMDI)?
Psychemedics Corp has 20 recent SEC filings from Jan 2024 to Mar 2025, including 7 8-K, 3 SC 13D/A, 3 SC 13G/A. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of PMDI filings?
Across 20 filings, the sentiment breakdown is: 1 bearish, 18 neutral, 1 mixed. The dominant sentiment is neutral.
Where can I find Psychemedics Corp SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Psychemedics Corp (PMDI) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Psychemedics Corp?
Key financial highlights from Psychemedics Corp's most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for PMDI?
The investment thesis for PMDI includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Psychemedics Corp?
Key executives identified across Psychemedics Corp's filings include Peter H. Kamin, David E. Danovitch, Esq., Enma Sagastume V.
What are the main risk factors for Psychemedics Corp stock?
Of PMDI's 17 assessed filings, 1 were flagged high-risk, 6 medium-risk, and 10 low-risk.
What are recent predictions and forward guidance from Psychemedics Corp?
Recent forward-looking statements from Psychemedics Corp include guidance on {"claim":"Renaissance Technologies will continue to adjust its stake in Psychemedics Corporation.","entity":"Renaissance.